We advance a portfolio of evidence-based inventions, which display clear clini-commercial advantage in the medical device, consumer health and health IT industries.
Our curation process, infrastructure and domain expertise allow us to accurately select and efficiently accelerate technologies to the optimal point for launching and capitalizing a commercial company, or transaction to an existing market operator. We call this the “relay point”. We work with creative clinical and scientific inventors and with industry leaders and global markets specialists to identify undervalued opportunities and advance them to the relay point.
HemoPalm is developing a POCT unit-use cartridge based blood analyzer with full enterprise capabilities, which brings lab-quality analysis to the bedside in critical care situations such as the ICU, NICU and ER.
Pharmatrac is an AI and data analytics driven personal medication management system that addresses the growing problem of non-adherence to treatment.
Commercializes products and services related to the management of decentralized fleets of medical devices and the data streams they produce.